LDcoder® is the world’s first and only diabetes early risk prediction blood test, that detects diabetes risk at least 4 years before prediabetes or diabetes actually develops.

LDcoder® uses patented blood biomarker panel, driven by AI algorithm, was developed from large international clinical studies conducted in 22 research institutes, hospitals, universities and pharma partners across Europe, the US and China.

LDcoder® is patented technology and CE-marked medical devices. It is now available for corporate health programs.

LDcoder® contains two protein assay kits (LDcoder human follistatin ELISA, and LDcoder human C-peptide ELISA), and one machine learning driven software LDcoder.

LDcoder® is performed on a tiny amount of blood sample (50 ul), and can be easily implemented in any clinical labs.

LDcoder® implemented the highest data security measures, with full data management and storage capacity established on both Google Cloud and AWS.